查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1661811

萊姆病診斷市場報告：2031 年趨勢、預測與競爭分析

Lyme Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球萊姆病診斷市場未來前景光明，在醫院和診所、病理實驗室、製藥業和臨床研究機構市場都存在機會。預計到 2031 年全球萊姆病診斷市場規模將達到 19 億美元，2025 年至 2031 年的複合年成長率為 3.6%。該市場的主要驅動力是政府重視改善醫療設施、開發萊姆病的新型診斷工具以及主要企業對萊姆病診斷研究和開發的興趣日益濃厚。

  • Lucintel 預測，在整個預測期內，血清學測試仍將是診斷測試類別中最大的一部分，因為這些測試專注於檢測受感染個體體內針對抗原產生的抗體。
  • 根據地區分類，由於醫療成本的上升和新產品的推出，預計北美將在預測期內實現最高成長。

萊姆病診斷市場的策略性成長機會

萊姆病診斷市場的策略性成長機會正在各種關鍵應用領域湧現。

  • 早期檢測技術：能夠早期準確檢測萊姆病的檢測方法的開發可以大大改善患者的治療效果。
  • 照護現場檢測：擴大就地檢驗選項以改善偏遠和服務不足地區的檢測服務，是一個成長機會。
  • 數位健康整合：利用數位健康工具和遠端醫療來診斷和管理萊姆病可以加強對病患的照護。
  • 擴大全球市場：隨著人們對蜱傳疾病的認知不斷提高，進入新興市場具有巨大的成長潛力。
  • 經濟高效的解決方案：透過開發適合不同醫療保健系統的經濟實惠的診斷測試來佔領新的細分市場。
  • 加強研究合作：與全球研究機構合作推廣診斷方法和技術可以促進創新。

萊姆病診斷市場的策略性成長機會受到早期檢測、PoC 測試和全球擴張方面的進步的推動，為市場發展提供了多種途徑。

萊姆病診斷市場促進因素與挑戰

萊姆病診斷市場受到影響其成長和發展的各種促進因素​​和挑戰的影響。

推動萊姆病診斷市場發展的因素有：

  • 提高認知：對萊姆病及其症狀的認知提高導致了對診斷測試的需求增加。
  • 監管支援：良好的法規環境和更新有助於引入新的診斷技術。
  • 研究經費：研發投入的增加正在刺激先進診斷技術的發展。
  • 衛生基礎設施：衛生基礎設施和診斷中心的改善擴大了偵測能力。
  • 全球擴張：人們對醫療保健的認知和投資不斷成長，將透過拓展新市場提供成長機會。

萊姆病診斷市場面臨的挑戰是：

  • 高成本：先進診斷測試的成本可能限制其普及，尤其是在資源匱乏的地區。
  • 診斷複雜性：萊姆病的診斷很複雜，包括與其他疾病的區分，可能具有挑戰性。
  • 監管障礙：獲得新診斷技術的監管要求和批准需要時間。
  • 市場競爭：診斷製造商之間的激烈競爭可能會影響市場佔有率和盈利。
  • 缺乏標準化：不同地區的診斷標準和實踐有所不同，這可能會影響結果的一致性。
  • 部分地區認知度低：部分地區對萊姆病的認知和了解不足，可能會阻礙市場成長。

萊姆病診斷市場受技術進步和認知不斷提高的推動，但面臨著高成本和監管障礙等挑戰，需要採取策略方法來確保持續成長和可及性。

目錄

第1章執行摘要

2. 全球萊姆病診斷市場：市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

  • 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
  • 全球萊姆病診斷市場趨勢（2019-2024 年）及預測（2025-2031 年）
  • 全球萊姆病診斷市場（按診斷測試）
    • 血清學檢測
    • 核酸擴增技術
    • 尿液抗原檢測
    • 淋巴球轉化試驗
    • 螢光螢光染色
    • PCR 分析
    • 其他
  • 全球萊姆病診斷市場（按技術）
    • 分子診斷
    • 腦部 MRI
    • 脊椎穿刺
    • 心臟超音波圖
    • 心電圖
    • 單株抗體
    • 流式細胞技術
    • 凝膠微滴法
    • 其他
  • 全球萊姆病診斷市場（按最終用途分類）
    • 醫院和診所
    • 病理實驗室
    • 製藥業
    • 臨床研究所
    • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

  • 全球萊姆病診斷市場（按地區）
  • 北美萊姆病診斷市場
  • 歐洲萊姆病診斷市場
  • 亞太地區萊姆病診斷市場
  • 世界其他地區的萊姆病診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球萊姆病診斷市場成長機會（按診斷測試）
    • 全球萊姆病診斷市場成長機會（按技術）
    • 全球萊姆病診斷市場成長機會（按最終用途分類）
    • 全球萊姆病診斷市場各區域成長機會
  • 全球萊姆病診斷市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球萊姆病診斷市場產能擴張
    • 全球萊姆病診斷市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • LEDLink Optics
  • Carclo Optics
  • Auer Lighting
  • LEDIL Oy
  • FRAEN
  • GAGGIONE
  • Bicom Optics
  • Darkoo Optics
  • Alere
  • Boulder Diagnostics
簡介目錄

The future of the global lyme disease diagnostic market looks promising with opportunities in the hospital & clinic, pathology lab, pharmaceutical industry, and clinical research institute markets. The global lyme disease diagnostic market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are government emphasis on enhancing healthcare facilities, the development of novel diagnostic tools for Lyme disease, and the increased interest of key players in Lyme disease diagnosis R&D.

  • Lucintel forecasts that, within the diagnostic test category, serological tests will remain the largest segment over the forecast period because they focus on detecting antibodies produced in the body of an infected individual in response to antigens.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to rising healthcare costs and the introduction of new products.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lyme Disease Diagnostic Market

Emerging trends in the Lyme disease diagnostic market highlight advancements in technology and evolving clinical practices.

  • Advanced Diagnostic Technologies: The development of more sensitive and specific tests, including PCR and next-generation sequencing, is enhancing diagnostic accuracy.
  • Point-of-Care Testing: Innovations in point-of-care testing are improving accessibility and convenience for patients and healthcare providers.
  • Integration with Digital Health: Digital health tools and telemedicine are being integrated into diagnostic processes to improve disease management.
  • Standardization of Diagnostic Criteria: Efforts are underway to standardize diagnostic criteria and guidelines to ensure consistency across regions.
  • Increased Research Funding: Growing investment in research is driving the development of new diagnostic methods and technologies.
  • Public Awareness Campaigns: Enhanced public health campaigns are raising awareness about Lyme disease and its symptoms, leading to earlier diagnosis.

Emerging trends in the Lyme disease diagnostic market reflect advancements in technology, an increased focus on point-of-care testing, and efforts to standardize diagnostic criteria, signaling a more accurate and accessible approach to Lyme disease management.

Recent Developments in the Lyme Disease Diagnostic Market

Recent developments in the Lyme disease diagnostic market demonstrate significant progress and innovation.

  • Introduction of New Tests: The market has seen the launch of improved diagnostic tests, including advanced PCR assays and high-resolution serological tests.
  • Regulatory Updates: Regulatory agencies are updating guidelines to incorporate new diagnostic technologies and improve accuracy.
  • Enhanced Research Initiatives: Increased funding and research are leading to the development of novel diagnostic methods and technologies.
  • Expansion of Diagnostic Centers: The establishment of specialized diagnostic centers in endemic regions is improving testing accessibility.
  • Increased Collaboration: Partnerships between research institutions and industry players are driving innovation in diagnostic technologies.
  • Focus on Rapid Testing: The development of rapid diagnostic tests is making it easier to diagnose Lyme disease promptly and accurately.

Recent developments in the Lyme disease diagnostic market highlight advancements in testing technologies, regulatory updates, and increased research, contributing to more accurate and accessible diagnostics.

Strategic Growth Opportunities for Lyme Disease Diagnostic Market

Strategic growth opportunities in the Lyme disease diagnostic market are emerging across various key applications.

  • Early Detection Technologies: Developing tests that offer early and accurate detection of Lyme disease can significantly improve patient outcomes.
  • Point-of-Care Testing: Expanding point-of-care testing options to increase accessibility in remote and underserved areas presents a growth opportunity.
  • Integration with Digital Health: Leveraging digital health tools and telemedicine for Lyme disease diagnostics and management can enhance patient care.
  • Global Market Expansion: Entering emerging markets with increasing awareness of tick-borne diseases offers significant growth potential.
  • Cost-Effective Solutions: Developing affordable diagnostic tests suitable for diverse healthcare systems can capture new market segments.
  • Enhanced Research Collaboration: Collaborating with global research institutions to advance diagnostic methods and technologies can drive innovation.

Strategic growth opportunities in the Lyme disease diagnostic market are driven by advancements in early detection, point-of-care testing, and global expansion, offering diverse avenues for market development.

Lyme Disease Diagnostic Market Driver and Challenges

The Lyme disease diagnostic market is shaped by various drivers and challenges influencing its growth and development.

The factors responsible for driving the Lyme disease diagnostic market include:

  • Increased Awareness: Growing awareness about Lyme disease and its symptoms is leading to higher demand for diagnostic tests.
  • Regulatory Support: Favorable regulatory environments and updates are facilitating the introduction of new diagnostic technologies.
  • Research Funding: Increased investment in research is driving the development of advanced diagnostic methods.
  • Healthcare Infrastructure: Improvements in healthcare infrastructure and diagnostic centers are expanding testing capabilities.
  • Global Expansion: Expanding into new markets with rising awareness and healthcare investments presents growth opportunities.

Challenges in the Lyme disease diagnostic market include:

  • High Costs: The cost of advanced diagnostic tests can limit accessibility, particularly in low-resource settings.
  • Diagnostic Complexity: The complexity of Lyme disease diagnostics, including differentiation from other diseases, can be challenging.
  • Regulatory Hurdles: Navigating regulatory requirements and approvals for new diagnostic technologies can be time-consuming.
  • Market Competition: Intense competition among diagnostic manufacturers can impact market share and profitability.
  • Lack of Standardization: Variability in diagnostic criteria and practices across regions can affect the consistency of results.
  • Limited Awareness in Some Regions: Inadequate awareness and understanding of Lyme disease in certain areas can hinder market growth.

The Lyme disease diagnostic market is driven by technological advancements and increased awareness but faces challenges such as high costs and regulatory hurdles, requiring strategic approaches to ensure sustained growth and accessibility.

List of Lyme Disease Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lyme disease diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lyme disease diagnostic companies profiled in this report include-

  • Abbott Laboratories
  • Qiagen
  • Biosystems
  • Bio-Rad Laboratories
  • Immunetics
  • Roche Diagnostics
  • T2 Biosystems
  • Graphene Frontiers
  • Alere
  • Boulder Diagnostics

Lyme Disease Diagnostic by Segment

The study includes a forecast for the global lyme disease diagnostic market by diagnostic test, technology, end use, and region.

Lyme Disease Diagnostic Market by Diagnostic Test [Analysis by Value from 2019 to 2031]:

  • Serological Test
  • Nucleic Acid Amplification Techniques
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • PCR Analysis
  • Others

Lyme Disease Diagnostic Market by Technology [Analysis by Value from 2019 to 2031]:

  • Molecular Diagnostics
  • Brain MRI
  • Spinal Tap
  • Echocardiogram
  • Electrocardiogram
  • Monoclonal Antibodies
  • Flow Cytometry
  • Gel Microdroplets
  • Others

Lyme Disease Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals & Clinics
  • Pathology labs
  • Pharmaceutical Industries
  • Clinical Research Institute
  • Others

Lyme Disease Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Lyme Disease Diagnostic Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major Lyme disease diagnostic producers in key regions: the USA, China, India, and Japan.

  • USA: In the U.S., the Lyme disease diagnostic market is evolving with advances in testing technologies and increased awareness. Recent developments include the introduction of more sensitive and specific diagnostic tests, such as improved PCR assays and serological tests that offer better early detection and differentiation from other tick-borne diseases. The CDC has been updating its guidelines to reflect new diagnostic methods and improve diagnostic accuracy. Additionally, there is a growing emphasis on developing point-of-care tests and integrating digital health tools to enhance disease management. Increased funding for research and public health campaigns is also contributing to market growth.
  • China: China's Lyme disease diagnostic market is expanding with improvements in testing technology and increased awareness of tick-borne diseases. Recent developments include the adoption of more advanced diagnostic tests and the establishment of specialized diagnostic centers in endemic regions. China is also investing in research to develop new diagnostic methods and enhance existing ones. Government health initiatives are focusing on improving disease surveillance and diagnostic capabilities. Additionally, there is a growing collaboration between Chinese and international research institutions to advance Lyme disease diagnostics and control measures.
  • India: In India, the Lyme disease diagnostic market is in the early stages of development, with recent advancements focusing on increasing awareness and improving diagnostic capabilities. Efforts are being made to introduce more reliable diagnostic tests and integrate them into public health programs. Research institutions are working on developing cost-effective diagnostic solutions suitable for the Indian healthcare system. Increased collaboration with international organizations and funding for research are helping to improve diagnostic infrastructure and support the development of better testing methods. Public health campaigns are also aiming to raise awareness about Lyme disease and its diagnosis.
  • Japan: Japan's Lyme disease diagnostic market is seeing gradual progress with the introduction of advanced diagnostic technologies and increased research activities. Recent developments include the implementation of more sensitive diagnostic tests, such as enhanced serological and molecular assays. The Japanese government is supporting research initiatives to improve diagnostic accuracy and early detection. There is also an emphasis on educating healthcare professionals and enhancing diagnostic capabilities in endemic areas. Collaborative efforts between Japanese research institutions and international organizations are contributing to the advancement of Lyme disease diagnostics.

Features of the Global Lyme Disease Diagnostic Market

Market Size Estimates: Lyme disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lyme disease diagnostic market size by diagnostic test, technology, end use, and region in terms of value ($B).

Regional Analysis: Lyme disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic test, technology, end use, and regions for the lyme disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lyme disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the lyme disease diagnostic market by diagnostic test (serological test, nucleic acid amplification techniques, urine antigen tests, lymphocytic transformation test, immunofluorescent staining, PCR Analysis, and others), technology (molecular diagnostics, brain MRI, spinal tap, echocardiogram, electrocardiogram, monoclonal antibodies, flow cytometry, gel microdroplets, and others), end use (hospitals & clinics, pathology labs, pharmaceutical industries, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lyme Disease Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Lyme Disease Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Lyme Disease Diagnostic Market by Diagnostic Test
    • 3.3.1: Serological Test
    • 3.3.2: Nucleic Acid Amplification Techniques
    • 3.3.3: Urine Antigen Tests
    • 3.3.4: Lymphocytic Transformation Test
    • 3.3.5: Immunofluorescent Staining
    • 3.3.6: PCR Analysis
    • 3.3.7: Others
  • 3.4: Global Lyme Disease Diagnostic Market by Technology
    • 3.4.1: Molecular Diagnostics
    • 3.4.2: Brain MRI
    • 3.4.3: Spinal Tap
    • 3.4.4: Echocardiogram
    • 3.4.5: Electrocardiogram
    • 3.4.6: Monoclonal Antibodies
    • 3.4.7: Flow Cytometry
    • 3.4.8: Gel Microdroplets
    • 3.4.9: Others
  • 3.5: Global Lyme Disease Diagnostic Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Pathology labs
    • 3.5.3: Pharmaceutical Industries
    • 3.5.4: Clinical Research Institute
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Lyme Disease Diagnostic Market by Region
  • 4.2: North American Lyme Disease Diagnostic Market
    • 4.2.1: North American Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.2.2: North American Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.3: European Lyme Disease Diagnostic Market
    • 4.3.1: European Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.3.2: European Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.4: APAC Lyme Disease Diagnostic Market
    • 4.4.1: APAC Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.4.2: APAC Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.5: ROW Lyme Disease Diagnostic Market
    • 4.5.1: ROW Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.5.2: ROW Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Diagnostic Test
    • 6.1.2: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for the Global Lyme Disease Diagnostic Market by End Use
    • 6.1.4: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Lyme Disease Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Lyme Disease Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lyme Disease Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: LEDLink Optics
  • 7.2: Carclo Optics
  • 7.3: Auer Lighting
  • 7.4: LEDIL Oy
  • 7.5: FRAEN
  • 7.6: GAGGIONE
  • 7.7: Bicom Optics
  • 7.8: Darkoo Optics
  • 7.9: Alere
  • 7.10: Boulder Diagnostics